Current Indian scenario

The pandemic has faced the scientific community with several serious hurdles. At the same time, this provided potential for new scientific pursuits, particularly in biotechnology. We have now begun to reap the benefits of the many scientific and medical advances accomplished in the last decade as a society. Advances in genomics, proteomics, and DNA sequencing technologies have permitted a more informed and tailored approach to medication design.India is ranked third in Asia and among the top 12 biotech destinations in the world. Because of rising economic prosperity, increased health consciousness, and a billion-plus population base, the Indian biotech industry is expected to grow significantly. The development of indigenous technologies/solutions of the Country is aiming at cost-effective and meet global standards of quality. The Indian start-up environment provides a unique opportunity to develop frugal innovative products. Unmet demands can be addressed with internationally competitive products and platform technologies. India has the potential to become a major biomanufacturing powerhouse.